BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21832278)

  • 21. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
    Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.
    Buharalioglu CK; Song CY; Yaghini FA; Ghafoor HU; Motiwala M; Adris T; Estes AM; Malik KU
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1043-55. PubMed ID: 21642504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
    Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
    Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.
    Lakshmikanthan S; Sobczak M; Chun C; Henschel A; Dargatz J; Ramchandran R; Chrzanowska-Wodnicka M
    Blood; 2011 Aug; 118(7):2015-26. PubMed ID: 21636859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies.
    Carbone CJ; Zheng H; Bhattacharya S; Lewis JR; Reiter AM; Henthorn P; Zhang ZY; Baker DP; Ukkiramapandian R; Bence KK; Fuchs SY
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19226-31. PubMed ID: 23129613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells.
    Olszewska-Pazdrak B; Hein TW; Olszewska P; Carney DH
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1162-70. PubMed ID: 19244479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
    Tae N; Lee S; Kim O; Park J; Na S; Lee JH
    Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.
    Bruns AF; Bao L; Walker JH; Ponnambalam S
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1193-7. PubMed ID: 19909245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells.
    Oshikawa J; Kim SJ; Furuta E; Caliceti C; Chen GF; McKinney RD; Kuhr F; Levitan I; Fukai T; Ushio-Fukai M
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H724-32. PubMed ID: 22101521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
    Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
    J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis.
    Ferrari G; Cook BD; Terushkin V; Pintucci G; Mignatti P
    J Cell Physiol; 2009 May; 219(2):449-58. PubMed ID: 19180561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
    Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.
    Rahman HNA; Wu H; Dong Y; Pasula S; Wen A; Sun Y; Brophy ML; Tessneer KL; Cai X; McManus J; Chang B; Kwak S; Rahman NS; Xu W; Fernandes C; Mcdaniel JM; Xia L; Smith L; Srinivasan RS; Chen H
    Circ Res; 2016 Mar; 118(6):957-969. PubMed ID: 26879230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses.
    Bhattacharya S; HuangFu WC; Dong G; Qian J; Baker DP; Karar J; Koumenis C; Diehl JA; Fuchs SY
    Oncogene; 2013 Sep; 32(36):4214-21. PubMed ID: 23045272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.